Kinetics of cytokine production in experimental autoimmune anterior uveitis (EAAU)

References

• Broekhuyse RM, Kuhlman ED, Winkens HJ, Van Vugt AHM. Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis, I: induction by a deter-gent-insoluble, intrinsic protein fraction of the retina pig-ment epithelium. Exp Eye Res. 1991;52:465–474.
   Google Scholar
• Broekhuyse RM, Kuhlman ED, Winkens HJ. Experimen-tal autoimmune anterior uveitis (EAAU), II: dose-depen-dent induction and adoptive transfer using a melanin-bound antigen of the retina pigment epithelium. Exp Eye Res. 1992;55:401–411.
   Google Scholar
• Broekhuyse RM, Kuhlman ED, Winkens HJ. Experimen-tal autoimmune anterior uveitis (EAAU), III: induction by immunization with purified uveal and skin melanins. Exp Eye Res. 1993;56:575–583.
   Google Scholar
• Broekhuyse RM, Kuhlman ED. Experimental autoimmune anterior uveitis: the preparation of uveitogenic ocular mel-anin. Invest Ophthalmol Vis Sci. 1993;34:698–700.
   PubMed Web of Science ®Google Scholar
• Chan CC, Hikita N, Dastgheib K, Whitcup SM, Gery I, Nussenblatt RB. Experimental melanin-protein induced uveitis in the Lewis rat: immunopathogenic process. Oph-thalmology. 1994;101:1275–1280.
   PubMed Web of Science ®Google Scholar
• Bora NS, Kim MC, Kabeer NH, et al. Experimental autoimmune anterior uveitis (EAAU): induction with mel-anin associated antigen from the iris and ciliary body. Invest Ophthalmol Vis Sci 1995;36:1056–1066.
   PubMed Web of Science ®Google Scholar
• Kim MC, Kabeer NH, Tandhasetti MT, Kaplan HJ, Bora NS. Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune ante-rior uveitis (EAAU). Curr Eye Res. 1995;14:703–710.
   Google Scholar
• Broekhuyse RM, Winkens HJ, Kuhlmann ED. Intraperito-neally injected melanin is highly uveitogenic. Exp Eye Res. 1996;62:199–200.
   PubMed Web of Science ®Google Scholar
• Simpson SC, Kaplan HJ, Bora NS. Uveitogenic proteins isolated from bovine iris and ciliary body. Eye. 1997; 11:206–208.
   Google Scholar
• Bora NS, Woon MD, Tandhasetti MT, Cirrito TP, Kaplan HJ. Induction of experimental autoimmune anterior uveitis (EAAU) by a self-antigen: melanin complex without adju-vant. Invest Ophthalmol Vis Sci. 1997;38:2171–2175.
   Google Scholar
• Brennan FM, Feldmann MF. Cytokines in Autoimmunity. Austin, TX: RG Landes Company; 1996.
   Google Scholar
• Guide for Care and Use of Laboratory Animals. Bethesda, MD: Office of Science and Health Reports; 1980. DHEW Publication No. (NIH) 80–23.
   Google Scholar
• Feldmann M, Brennan FM, Chantry D, et al. Cytokine production in the rheumatoid joint: implications for treat-ment. Annals Rheumatic Diseases. 1990;49:480–486.
   PubMed Web of Science ®Google Scholar
• Harigai M, Hara M, Kitani A, et al. Interleukin I and tumor necrosis factor-a synergistically increase the pro-duction of interleukin 6 in human synovial fibroblast. J Clin Lab ImmunoL 1991;34:107–113.
   PubMedGoogle Scholar
• Ruschen S, Stellberg W, Warnatz H. Kinetics of cytokine secretion by mononuclear cells of the blood from rheuma-toid arthritis patients are different from those of healthy controls. Clin Exp ImmunoL 1992;89:32–37.
   Google Scholar
• Chung IY, Gavin Norris J, Benveniste EN. Differential tumor necrosis factor a expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J Exp Med. 1991;173:801–811.
   PubMed Web of Science ®Google Scholar
• Issazadeh S. Mustafa M, Ljundahl A, et al. Interferon-y, interleukin 4 and transforming growth factor 13 in experi-mental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central ner-vous system and lymphoid cells. J Neurosci Res. 1995;40: 579–590.
   PubMed Web of Science ®Google Scholar
• Issazadeh S, Ljundahl A, Hojeberg B, Mustafa M, Olsson T. Cytokine production in the central nervous system ofLewis rats with experimental autoimmune encephalomy-elitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor a and tumor necrosis factor 13. J NeuroimmunoL 1995;61: 205–212.
   Google Scholar
• Renno T, Krakowski M, Piccirillo C, Lin JY, Owens T. TNF-a expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. J ImmunoL 1995; 154:944–953.
   Google Scholar
• Eng LF, Ghirnikar RS, Lee YL. Inflammation in EAE: role of chemokine/cytokine expression by resident and infil-trating cells. Neurochemical Res. 1996;21:511–525.
   Google Scholar
• Planck SR, Huang XN, Robertson JE, Rosenbaum JT. Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci. 1994;35: 924–930.
   PubMed Web of Science ®Google Scholar
• De Vos AF, van Haren MAC, Verhagen C, Hoekzema R, Kijlstra A. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994;35:1100–1106.
   PubMed Web of Science ®Google Scholar
• De Vos AF, Klaren VNA, Kijlstra A. Expression of mul-tiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994;35: 3873–3883.
   Google Scholar
• Yosida M, Yoshimura N, Hangai M, Tanihara H, Honda Y Interleukin-la, interleukin- 113, and tumor necrosis factor gene expression in endotoxin-induced uveitis. Invest Oph-thalmol Vis Sci 1994;35:1107–1113.
   PubMed Web of Science ®Google Scholar
• Kasner L, Chan CC, Whitcup SM, Gery I. The paradoxical effect of tumor necrosis factor alpha (TNF-a) in endo-toxin-induced uveitis. Invest Ophthalmol Vis Sci. 1993;34: 2911–2917.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT, Boney RS. Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor. Reg ImmunoL 1993;5:299–303.
   PubMedGoogle Scholar
• De Vos AF, Van Haren MAC, Verhagen C, Hoekzema R, Kijlstra A. Systemic anti-tumor necrosis factor antibodies treatment exacerbates endotoxin-induced uveitis in the rat. Exp Eye Res. 1995;61:667–675.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Yamakawa T, Sugita M, et al. The role of tumor necrosis factor-alpha in the induction of experimen-tal autoimmune uveoretinitis in mice. Invest Ophthalmol Vis Sci. 1994;35:3884–3889.
   PubMed Web of Science ®Google Scholar
• Sartani G, Silver PB, Rizzo LV, et al. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimen-tal autoimmune uveoretinitis in mice by inhibiting antigen priming. Invest Ophthalmol Vis Sci. 1996; 37:2211–2218.
   PubMed Web of Science ®Google Scholar
• Dick AD, McMenamin PG, Korner H, et al. Inhibition of tumor necrosis factor activity minimizes target organ dam-age in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J ImmunoL 1996;26:1018–1025.
   PubMed Web of Science ®Google Scholar
• Ferber IA, Brocke S, Taylor-Edwards C, et al. Mice with a disrupted IFN-gamma gene are susceptible to the induc-tion of experimental autoimmune encephalomyelitis (EAE). J ImmunoL 1996;156:5.
   Google Scholar
• Caspi RR, Chan CC, Grubbs PB, et al. Endogenous sys-temic IFN-gamma has a protective role against ocular autoimmunity in mice. J Immunol. 1994;152:890–895.
   PubMed Web of Science ®Google Scholar
• Jones LS, Rizzo LV, Agarwal RK, et al. IFN-y-deficient mice develop experimental autoimmune uveitis in the con-text of a deviant effector response. J Immunol. 1997;158: 5997–6005.
   PubMed Web of Science ®Google Scholar
• Kennedy MK, Torrance DS, Picha KS, Mohler KM. Anal-ysis of cytokine mRNA expression the central nervous system of mice with experimental autoimmune encephalo-myelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol. 1992;149:2496–2505.
   PubMed Web of Science ®Google Scholar
• Charteris DG, Lightman SL. In vivo lymphokine produc-tion in experimental autoimmune uveoretinits. J Immunol. 1993;78:387–392.
   Google Scholar
• Munoz JJ. Action of pertussigen (pertussis toxin) on the host immune system. In: Wardlaw AC, Parton R., eds. Pathogenesis and Immunity in Pertussis . London: John Wiley & Sons; 1988:173–192.
   Google Scholar
• Rosenbaum JT, Angell E. Paradoxical effects of IL-10 in endotoxin-induced uveitis. J Immunol. 1995;155:4090–4094.
   PubMed Web of Science ®Google Scholar
• Li Q, Sun B, Dastgheib K, Chan CC. Suppressive effect of transforming growth factor 131 on the recurrence of experi-mental melanin protein-induced uveitis: upregulation of ocular interleukin-10. Clin Immunol & Immunopathol. 1996;81:55–61.
   PubMedGoogle Scholar